Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Triple-Blind, Parallel Study to Investigate the Effect of Losartan Versus Atenolol on the Reduction of Morbidity and Mortality in Hypertensive Patients With Left Ventricular Hypertrophy

NCT00338260 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00338260
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00338260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Triple-Blind, Parallel Study to Investigate the Effect of Losartan Versus Atenolol on the Reduction of Morbidity and Mortality in Hypertensive Patients With Left Ventricular Hypertrophy
Lead sponsor
Organon and Co
Phase
Phase 3
Overall status
Completed
Start date
June 30, 1995
Completion date
November 30, 2001
Enrollment
496 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension and left ventricular hypertrophy (thickening of the main pumping chamber of the heart)